Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...
Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...
Semaglutide vs liraglutide treatment demonstrated superior weight loss at 1 year and 10% weight loss achievement among patients with obesity.